Exagen Inc. (XGN)
NASDAQ · Healthcare
Exagen Inc. Shareholder Equity 2018–2025
Exagen Inc. annual shareholder equity history from 2018 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Exagen Inc. shareholder equity as of December 31, 2025: 17.4M, a 82.90% increase year-over-year.
- Exagen Inc. shareholder equity for 2025 were 17.4M, a 82.90% increase from 2024.
- Exagen Inc. shareholder equity for 2024 were 9.5M, a 57.96% decrease from 2023.
- Exagen Inc. shareholder equity for 2023 were 22.7M, a 46.55% decrease from 2022.
- Exagen Inc. shareholder equity for 2022 were 42.5M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Exagen Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $17 |
| 2024 | $10 |
| 2023 | $23 |
| 2022 | $42 |
| 2021 | $85 |
| 2020 | $42 |
| 2019 | $56 |
| 2018 | $-112 |
Exagen Inc. Shareholder Equity — FAQ
Exagen Inc. (XGN) shareholder equity over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see XGN's shareholder equity history?
The chart and table above show Exagen Inc.'s shareholder equity by year and by quarter, including the growth rate.